Results 141 to 150 of about 108,375,652 (210)

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis. [PDF]

Front Immunol
Zhao J, Liu Z, Wang J.
europepmc   +1 more source

Substance P and NK-1R in Dengue: A First Serological Investigation. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Ahmad S, Sarwar N, John A, Mehboob Z, Almansouri M, Badoghaish W.   +7 more
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Opioid Peptide Hybrids as Multifunctional Analgesic Ligands: Emphasis on Intracellular Signaling. [PDF]

Pharmaceuticals (Basel)
Cecherz I, Waśkiewicz J, Dudek A, Polatyński D, Wtorek K, Piekielna-Ciesielska J.   +5 more
europepmc   +1 more source

Adverse Event Reporting Patterns Associated with Concomitant Use of 5-HT3 and NK-1 Receptor Antagonists: A Large-Scale Spontaneous-Reporting Analysis. [PDF]

Pharmaceuticals (Basel)
Zhao R, Tang S, Han M, Hu H, Guo J, Lv M, Sun J, Zhou X.   +7 more
europepmc   +1 more source

Refractory nausea in an 86-year-old patient after surgery. [PDF]

CMAJ
Bhattacharjee A, Gruber A, MacMillan TE, Shah R.   +3 more
europepmc   +1 more source

Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial. [PDF]

Menopause
Wang Y, Wang X, Wang W, Lin J, He Y, Chen H, Shou H, Ai X, Zhang Q, Cai Y, Wu Y, Guo R, Hu L, Chen H, Xiang W, Pan C, Yu Q.   +16 more
europepmc   +1 more source

NK2R signaling governs intestinal lipid mobilization and mucosal inflammation. [PDF]

Elife
Perez PA, Liu CC, Ferrari A, Littlejohn NK, Kennelly JP, Robinson EM, Nguyen-Tran VTB, Athanacio J, Joesph SB, Amso Z, Tontonoz P, Srinivasan S.   +11 more
europepmc   +1 more source

Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]

In Vivo
Kawamura Y, Yoshida K, Morita H, Nakai M, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Yamaguchi A, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Watanabe S, Watanabe A, Sugiura M.   +17 more
europepmc   +1 more source